Levine Mark S. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$2.8M

Insider Activity of Levine Mark S.

Biography of Levine Mark S.

No biography is available at this moment.

2024-11-20SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,650
0.0024%
$25.45$92,893-33.34%
2024-10-23SaleImmunovant, Inc.
IMVT
Chief Legal Officer
4,361
0.003%
$29.53$128,780-41.89%
2024-10-16SaleImmunovant, Inc.
IMVT
Chief Legal Officer
2,860
0.002%
$28.79$82,339-40.2%
2024-08-21SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,295
0.0022%
$31.86$104,976-37.88%
2024-07-24SaleImmunovant, Inc.
IMVT
Chief Legal Officer
4,015
0.0027%
$27.76$111,456-18.34%
2024-07-17SaleImmunovant, Inc.
IMVT
Chief Legal Officer
2,505
0.0017%
$29.69$74,382-21.5%
2024-05-22SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,242
0.0022%
$29.65$96,125-10.67%
2024-04-24SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,963
0.0028%
$28.90$114,531-4.34%
2024-04-17SaleImmunovant, Inc.
IMVT
Chief Legal Officer
9,827
0.0069%
$29.06$285,554-2.22%
2024-02-22SaleImmunovant, Inc.
IMVT
Chief Legal Officer
2,134
0.0015%
$36.15$77,144-19.81%
2024-01-26SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,027
0.0021%
$37.92$114,778-23.45%
2023-11-22SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,252
0.0023%
$32.78$106,598-7.02%
2023-10-25SaleImmunovant, Inc.
IMVT
Chief Legal Officer
4,107
0.0029%
$34.66$142,349-9.14%
2023-08-24SaleImmunovant, Inc.
IMVT
Chief Legal Officer
12,286
0.0094%
$20.30$249,406+57.32%
2023-07-26SaleImmunovant, Inc.
IMVT
Chief Legal Officer
3,917
0.0032%
$21.63$84,725+45.42%
2023-04-25SaleImmunovant, Inc.
IMVT
Chief Legal Officer
2,633
0.0021%
$16.29$42,892+92.95%
2023-01-26SaleImmunovant, Inc.
IMVT
Chief Legal Officer
10,156
0.0083%
$18.51$187,988+20.74%
2017-06-01SaleMinerva Neurosciences, Inc.
NERV
SVP,General Counsel & Sec.
35,000
0.0772%
$8.10$283,325-34%
2017-01-04SaleMinerva Neurosciences, Inc.
NERV
SVP,General Counsel & Sec.
35,000
0.0962%
$12.00$420,000-39.68%
Total: 19
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.